Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.52
-1.48 (-5.50%)
Nov 6, 2026, 2:12 PM EST - Market open
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.23 billion as of November 6, 2026. It is the 4,659th most valuable company in the world and the 1,405th biggest in the United States. Its market cap has increased by 6.38% in one year.
Market Cap
3.23B
Enterprise Value
3.09B
1-Year Change
6.38%
Global Rank
Country Rank
#1,405 United States
Category
ChartMarket Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.23B, an increase of 312.58%. That is a compound annual growth rate of 23.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 4.31B | 21.05% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.80B |
| Legend Biotech | 4.41B |
| Definium Therapeutics | 4.39B |
| Edgewise Therapeutics | 4.08B |
| AbCellera Biologics | 3.98B |
| Relay Therapeutics | 3.95B |
| Iovance Biotherapeutics | 3.94B |
| Tango Therapeutics | 3.91B |